Patent details

EP2627319 Title: PHARMACEUTICAL COMPOSITIONS CONTAINING A DGAT1 INHIBITOR

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2627319
WO Application Number:
US2011056275
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP11779278.8
WO Publication Number:
WO2012051488
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:

Dates

Filing date:
14/10/2011
Grant date:
21/11/2018
EP Publication Date:
21/08/2013
WO Publication Date:
19/04/2012
Claims Translations Received Date:
Claims Translation B1 Received Date:
14/02/2019
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
21/11/2018
EP B1 Publication Date:
21/11/2018
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
13/10/2031
Lapsed By Expiration Date:
Patent Validated Date:
23/03/2019
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
21/11/2018
 
 

 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 BASEL, Switzerland (CH)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
22/03/2019
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
WEN, Hong
Address:
North Potomac Maryland 20878, United States of America (US)

2

Name:
KUMARAPERUMAL, Natrajan
Address:
Wayne New Jersey 07470, United States of America (US)

3

Name:
NAUSE, Richard
Address:
New Jersey 07936-1080, United States of America (US)

Priority

Priority Patent Number:
393103 P
Priority Date:
14/10/2010
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 9/20; A61K 9/28; A61K 31/444; A61K 47/20; A61K 47/26; A61K 47/38;

Publication

Bulletin

1

Bulletin Heading:
EP3
Journal edition number:
13/19
Publication date:
27/03/2019
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

2

Bulletin Heading:
EP2
Journal edition number:
48/18
Publication date:
21/11/2018
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201847
Publication date:
21/11/2018
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
31/10/2025
Annual Fee Number:
15
Annual Fee Amount:
900 Euro
Last Annual Payment Date:
26/08/2024
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
800 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
22/03/2019 Outgoing Correspondence Letter no formal defects 1 PDF /7/9/4/1/4/0800341497/docs/ep11779278.8_0_261029l271.pdf
14/02/2019 Claims First filed claims 3 PDF /7/9/4/1/4/0800341497/docs/ep11779278.8_1_claims20190214104519153.pdf